Durability of immune responses to the BNT162b2 mRNA vaccine
“Six months after receiving the second dose of the two-shot vaccine from Pfizer Inc and BioNTech SE, many recipients no longer have vaccine-induced antibodies that can immediately neutralize worrisome variants of the coronavirus, a new study suggests.”
This reinforces the need for protection beyond vaccination. Spray it with Cold & Flu Guard.
Recent Posts
- Nature’s Answer To Respiratory Infections
- Durability of immune responses to the BNT162b2 mRNA vaccine
- COLD & FLU GUARD™ could represent an important and novel complementary interventions in the fight against the Delta, Beta and Gamma Variants of Concern
- COOPER PHARMA and OSI Sign Distribution Agreement to protect and prevent against respiratory viruses including the one that causes COVID-19
- Dr Glogauer & Dr Freedman Discuss Cold & Flu Guard™ Data